Pages that link to "Q73510912"

The following pages link to Intranasal Immunization Is Superior to Vaginal, Gastric, or Rectal Immunization for the Induction of Systemic and Mucosal Anti-HIV Antibody Responses (Q73510912):

Displaying 39 items.

• Vaccines against human diarrheal pathogens: current status and perspectives (Q33578045) (← links)
• Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1. (Q33665793) (← links)
• Route of Infection That Induces a High Intensity of Gamma Interferon-Secreting T Cells in the Genital Tract Produces Optimal Protection againstChlamydia trachomatisInfection in Mice (Q33760450) (← links)
• Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue (Q33769366) (← links)
• Microparticles for intranasal immunization (Q34343274) (← links)
• Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization (Q34357220) (← links)
• Current progress in the development of a prophylactic vaccine for HIV-1 (Q34502108) (← links)
• Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins. (Q34976881) (← links)
• Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs (Q35275117) (← links)
• Schistosoma mansoni Infection in Ugandan Men Is Associated with Increased Abundance and Function of HIV Target Cells in Blood, but Not the Foreskin: A Cross-sectional Study (Q35763313) (← links)
• Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens (Q36391905) (← links)
• Mucosal vaccines: the promise and the challenge (Q36402244) (← links)
• Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses (Q36483586) (← links)
• Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model (Q37365361) (← links)
• An African perspective on mucosal immunity and HIV-1. (Q37472898) (← links)
• Strategies for optimizing targeting and delivery of mucosal HIV vaccines (Q37554135) (← links)
• Mucosal Vaccine Development Based on Liposome Technology (Q37581129) (← links)
• Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting (Q37596422) (← links)
• Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines (Q37859981) (← links)
• Plant-derived antigens as mucosal vaccines (Q37910821) (← links)
• Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses (Q40735997) (← links)
• Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies (Q43654259) (← links)
• Evaluation of interleukin 1 as a mucosal adjuvant in immunization with Streptococcus sobrinus cells by tonsillar application in rabbits (Q44006230) (← links)
• Effect of route of vaccination with vaccinia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection (Q44667687) (← links)
• DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector (Q44895700) (← links)
• Mucosal immunization against dental caries with plasmid DNA encoding pac gene of Streptococcus mutans in rats (Q44933266) (← links)
• Long-Term Control of Simian Immunodeficiency Virusmac251 Viremia to Undetectable Levels in Half of Infected Female Rhesus Macaques Nasally Vaccinated with Simian Immunodeficiency Virus DNA/Recombinant Modified Vaccinia Virus Ankara (Q45369122) (← links)
• Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge (Q45741831) (← links)
• Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1. (Q50999753) (← links)
• Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target (Q51372135) (← links)
• Intranasal, rectal and intraperitoneal immunization with protoxin Cry1Ac from Bacillus thuringiensis induces compartmentalized serum, intestinal, vaginal and pulmonary immune responses in Balb/c mice. (Q52582117) (← links)
• Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24Gag. (Q54492375) (← links)
• Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses (Q64127566) (← links)
• Antibody responses to a mucosally delivered HIV-1 gp120-derived C4/V3 peptide. (Q64945136) (← links)
• Rectal immunization with antigen-containing microspheres induces stronger Th2 responses than oral immunization: a new method for vaccination (Q74841496) (← links)
• Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease (Q79222958) (← links)
• Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice (Q84084301) (← links)
• Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen (Q91862911) (← links)
• Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection (Q94451631) (← links)